EUVIMEDEUVIMED entdecken
Crossref

In Situ Bioconjugation of Synthetic Peptides onto Universal Chimeric Antigen Receptor T Cells for Targeted Cancer Immunotherapies

Ian I Cardle iD, Dylan R Scherer, Michael C Jensen, Suzie H Pun iD, Drew L Sellers iD

ACS Nano · 2025

DOI: 10.1021/acsnano.4c16824 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, 2025. Verfasst von Ian I Cardle und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioengineering, University of Washington, Seattle, Washington 98195-5061, United States. Hauptthemen laut MEDLINE: Receptors, Chimeric Antigen, Peptides, Immunotherapy, Immunotherapy, Adoptive. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 85 Literaturangaben. Gefördert von: NINDS NIH HHS, NCI NIH HHS, NIA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Chimeric AntigenPeptidesImmunotherapyImmunotherapy, AdoptiveT-LymphocytesNeoplasmsReceptors, Antigen, T-CellAnimalsHumansMiceCell Line, Tumor

Stichwörter der Autor:innen

CAR T cellsSpyCatcherimmunotherapypeptidessynthetic adaptors

Substanzen

Receptors, Chimeric AntigenPeptidesReceptors, Antigen, T-Cell

Autor:innen und Institutionen

  • Department of Bioengineering, University of Washington, Seattle, Washington 98195-5061, United States.
  • Seattle Children's Therapeutics, Seattle, Washington 98101, United States.
  • Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, United States.

ORCID-Profile: Ian I Cardle, Suzie H Pun, Drew L Sellers

Förderung

  • NINDS NIH HHS
  • NCI NIH HHS
  • NIA NIH HHS
  • National Science Foundation Graduate Research Fellowship Program
  • National Cancer Institute
  • National Institute of Neurological Disorders and Stroke
  • National Institute on Aging

Zitieren

APA

Cardle, I. I., Scherer, D. R., Jensen, M. C., Pun, S. H., & Sellers, D. L. (2025). In Situ Bioconjugation of Synthetic Peptides onto Universal Chimeric Antigen Receptor T Cells for Targeted Cancer Immunotherapies. ACS Nano. https://doi.org/10.1021/acsnano.4c16824

Vancouver

Cardle II, Scherer DR, Jensen MC, Pun SH, Sellers DL. In Situ Bioconjugation of Synthetic Peptides onto Universal Chimeric Antigen Receptor T Cells for Targeted Cancer Immunotherapies. ACS Nano. 2025. doi:10.1021/acsnano.4c16824

BibTeX
@article{Cardle2025,
  author = {Cardle, Ian I and Scherer, Dylan R and Jensen, Michael C and Pun, Suzie H and Sellers, Drew L},
  title = {In Situ Bioconjugation of Synthetic Peptides onto Universal Chimeric Antigen Receptor T Cells for Targeted Cancer Immunotherapies},
  journal = {ACS Nano},
  year = {2025},
  doi = {10.1021/acsnano.4c16824}
}
Kostenlos starten →